# PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France

> **NCT07748572** · — · RECRUITING · sponsor: **Phenox GmbH** · enrollment: 200 (estimated)

## Conditions studied

- Intracranial Aneurysms

## Interventions

- **DEVICE:** Aneurysm treatment with a Flow Modulation Device

## Key facts

- **NCT ID:** NCT07748572
- **Lead sponsor:** Phenox GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-07
- **Primary completion:** 2028-10
- **Final completion:** 2028-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748572, "PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07748572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*